Bioavailability of gentamicin and vancomycin released from an antibiotic containing bone cement in patients undergoing a septic one-stage total hip arthroplasty (THA) revision: A monocentric open clinical trial

HIP International

Volumn 26, Issue 1, 2016, Pages 90-96

  Kendoff, Daniel O ^a   Gehrke, Thorsten ^b   Stangenberg, Peter ^b   Frommelt, Lars ^c   Bösebeck, Hans ^d  

^a HELIOS KLINIKUM BERLIN BUCH   (Germany)

^b ENDO Klinik   (Germany)

^c Microbiology Laboratory Dr Frommelt   (Germany)

^d Heraeus Medical GmbH   (Germany)

Author keywords

Antibiotic loaded bone cement; Clinical investigation; Hip revision; Periprosthetic infection; Release kinetics

Indexed keywords

ANTIBIOTIC BONE CEMENT; C REACTIVE PROTEIN; GENTAMICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BONE CEMENT;

ADULT; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); CORYNEBACTERIUM AMYCOLATUM; COXITIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG TOLERABILITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITALIZATION; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; PERIPROSTHETIC JOINT INFECTION; TOTAL HIP PROSTHESIS; ADVERSE EFFECTS; AGED; BIOAVAILABILITY; CLINICAL TRIAL; HIP PROSTHESIS; HIP REPLACEMENT; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; PROSTHESIS-RELATED INFECTIONS; REOPERATION; STAPHYLOCOCCAL INFECTIONS;

AGED; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BIOLOGICAL AVAILABILITY; BONE CEMENTS; FEMALE; GENTAMICINS; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; REOPERATION; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84957928477     PISSN: 11207000     EISSN: None     Source Type: Journal    
DOI: 10.5301/hipint.5000307     Document Type: Article

References (27)

1. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23(7):984-991.
2. Anagnostakos K, Fürst O, Kelm J. Antibiotic-impregnated PMMA hip spacers: Current status. Acta Orthop. 2006;77(4):628-637.
3. Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibioticimpregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007;89(4):871-882.
4. Senthi S, Munro JT, Pitto RP. Infection in total hip replacement: meta-analysis. Int Orthop. 2011;35(2):253-260.
5. Beswick AD, Elvers KT, Smith AJ, Gooberman-Hill R, Lovering A, Blom AW. What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patients. BMC Med. 2012;10:18.
6. Lange J, Troelsen A, Thomsen RW, Søballe K. Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis. Clin Epidemiol. 2012;4:57-73.
7. Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin Orthop Relat Res. 2009;467(7):1732-1739.
8. David MZ, Daum RS. Community-associated methicillinresistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616-687.
9. EARSS. European Antimicrobial Resistance Surveillance System: EARSS Annual Report 2008: On-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. The National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands. 2009:180.
10. Levine DP. Vancomycin: understanding its past and preserving its future. South Med J. 2008;101(3):284-291.
11. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1): 82-98.
12. Nickinson RS, Board TN, Gambhir AK, Porter ML, Kay PR. The microbiology of the infected knee arthroplasty. Int Orthop. 2010;34(4):505-510.
13. Springer BD, Lee GC, Osmon D, Haidukewych GJ, Hanssen AD, Jacofsky DJ. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res. 2004;427:47-51.
14. Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis. 2008;47(11): 1403-1409.
15. Frommelt L, Kühn K-D. Antibiotic-Loaded Cement. In: Breusch SJ, Malchau H, eds. The Well-Cemented Total Hip Arthroplasty: Theory and Practice. Berlin; New York, Springer 2005;86-92.
16. Kresken M, Hafner D, Korber-Irrgang B. [PEG - Resistance Study 2010 - Subproject H: Epidemiology and prevalence of resistance in clinically important pathogens from the Hospital area to antibiotics]. [Article in German]. Antiinfectives Intelligence Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation. 2013;1(1):1-68.
17. Hendriks JG, Neut D, van Horn JR, van der Mei HC, Busscher HJ. Bacterial survival in the interfacial gap in gentamicinloaded acrylic bone cements. J Bone Joint Surg Br. 2005;87(2): 272-276.
18. Gallo J, Kolár M, Florschütz AV, Novotný R, Pantůcek R, Kesselová M. In vitro testing of gentamicin-vancomycin loaded bone cement to prevent prosthetic joint infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1):153-158.
19. Salvati EA, Callaghan JJ, Brause BD, Klein RF, Small RD. Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Relat Res. 1986;(207):83-93.
20. Chohfi M, Langlais F, Fourastier J, Minet J, Thomazeau H, Cormier M. Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cement. Int Orthop. 1998;22(3):171-177.
21. Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop. 2009;80(2):193-197.
22. Hsieh PH, Huang KC, Tai CL. Liquid gentamicin in bone cement spacers: in vivo antibiotic release and systemic safety in twostage revision of infected hip arthroplasty. J Trauma. 2009; 66(3):804-808.
23. Gupta A, Biyani M, Khaira A. Vancomycin nephrotoxicity: myths and facts. Neth J Med. 2011;69(9):379-383.
24. Begg EJ, Barclay ML. Aminoglycosides-50 years on. Br J Clin Pharmacol. 1995;39(6):597-603.
25. Ferraris S, Miola M, Bistolfi A, et al. In vitro comparison between commercially and manually mixed antibiotic-loaded bone cements. J Appl Biomater Biomech. 2010;8(3):166-174.
26. Laine JC, Nguyen TQ, Buckley JM, Kim HT. Effects of mixing techniques on vancomycin-impregnated polymethylmethacrylate. J Arthroplasty. 2011;26(8):1562-1566.
27. Miller R, McLaren A, Leon C, McLemore R. Mixing method affects elution and strength of high-dose ALBC: a pilot study. Clin Orthop Relat Res. 2012;470(10):2677-2683.